News and Updates

*PDF documents require Adobe's Free Acrobat ^® Reader^TM

News and Updates:

	Net Tangible Asset Backing – June 2010 02 July 2010
	Share buyback and cancellation 15 June 2010
	Net Tangible Asset Backing – May 2010 03 June 2010
	Share buyback and cancellation 17 May 2010
	Daily share cancellation notice 21 April 2010
	Net Tangible Asset Backing – March 2010 01 April 2010
	Net Tangible Asset Backing – February 2010 02 March 2010
	Net Tangible Asset Backing – January 2010 02 February 2010
	Net Tangible Asset Backing – December 2010 25 January 2010
	Share buyback and cancellation 14 December 2009
	Net Tangible Asset Backing – November 2009 7 December 2009
	Share buyback program 2010 24 November 2009
	Share buyback and cancellation 18 November 2009
	Results of AGM 18 November 2009
	BTC 2009 AGM presentation 17 November 2009
	BTC 2009 AGM Chairman’s address 17 November 2009
	Net Tangible Asset Backing – October 2009 1 November 2009
	Share buyback and cancellation 13 October 2009
	Net Tangible Asset Backing – September 2009 12 October 2009
	BTC 2009 AGM Notice of Meeting 30 September 2009
	BTC 2009 AGM Proxy Form 30 September 2009
	BioTech Capital Annual Report 2009 29 September 2009
	Share buyback and cancellation 16 September 2009
	BTC 2009 Financial Report for 4E 28 August 2009
	BTC 2009 Appendix 4E 28 August 2009
	Share buyback and cancellation 18 August 2009
	Net Tangible Asset Backing – July 2009 03 August 2009
	Share buyback and cancellation 20 July 2009
	Net Tangible Asset Backing – June 2009 03 July 2009
	Net Tangible Asset Backing – May 2009 04 June 2009
	Net Tangible Asset Backing – April 2009 06 April 2009
	Net Tangible Asset Backing – March 2009 03 April 2009
	Share buyback and cancellation 23 March 2009
	Net Tangible Asset Backing – February 2009 03 March 2009
	Stem Cell Sciences – Sale of Assets to Stem Cells Inc 03 March 2009
	BioTech Capital Dec 2008 Letter to Shareholders 25 February 2009
	BioTech Capital Dec 2008 Interim Financial Report 25 February 2009
	BioTech Capital Dec 2008 Appendix 4D Report 25 February 2009
	Net Tangible Asset Backing – January 2009 2 February 2009
	Net Tangible Asset Backing – December 2008 20 January 2009
	Net Tangible Asset Backing – November 2008 4 December 2008
	BTC Share Buyback Appendix 3C 24 November 2008
	Final Director’s Interest Notice – Lisa McIntyre 21 November 2008
	Chairman’s Address – BTC AGM 2008 19 November 2008
	Managing Director’s presentation – BTC AGM 2008 19 November 2008
	Results of Meeting – BTC AGM 2008 19 November 2008
	Retirement of Dr Lisa McIntyre 19 November 2008
	Net Tangible Asset Backing – October 2008 03 November 2008
	Net Tangible Asset Backing – September 2008 06 October 2008
	Biotech Capital Annual Report 2008 30 September 2008
	Net Tangible Asset Backing – August 2008 04 September 2008
	BTC 2008 Financial Report 28 August 2008
	BTC 2008 Appendix 4E 28 August 2008
	Boardroom Radio Interview – Generic Health Pty Ltd secures strategic partnership 26 August 2008
	Generic Health Pty Ltd secures strategic partnership from Lupin Ltd 25 August 2008
	Net Tangible Asset Backing – July 2008 05 August 2008
	Net Tangible Asset Backing – June 2008 03 July 2008
	Net Tangible Asset Backing – May 2008 04 June 2008
	Change in substantial shareholding 22 May 2008
	Boardroom Radio Interview – Generic Health and Sensear 22 May 2008
	Sensear wins DuPont innovation award 20 May 2008
	Generic Health secures partnership with world’s fifth largest generics company 19 May 2008
	Net Tangible Asset Backing – April 2008 05 May 2008
	Net Tangible Asset Backing – March 2008 04 April 2008
	Ceasing to be a substantial shareholder 12 March 2008
	Net Tangible Asset Backing – February 2008 06 March 2008
	BioTech Capital Investor Newsletter Feb 2008 29 February 2008
	BioTech Capital Dec 2007 Appendix 4D report 29 February 2008
	BioTech Capital Dec 2007 Interim Financial Report 29 February 2008
	Net Tangible Asset Backing – January 2008 4 February 2008
	Net Tangible Asset Backing – December 2007 15 January 2008
	Change in substantial shareholding 18 December 2007
	Net Tangible Asset Backing – November 2007 4 December 2007
	Boardroom Radio Interview – Generic Health Pty Ltd 23 November 2007
	2007 AGM Results of Meeting 21 November 2007
	2007 AGM Boardroom Radio link 21 November 2007
	Chairman’s Address – 2007 AGM 20 November 2007
	Managing Director’s Presentation – 2007 AGM 20 November 2007
	BTC invests $2.2m in Generic Health Pty Ltd 19 November 2007
	Change in substantial shareholding 7 November 2007
	Net Tangible Asset Backing – October 2007 2 November 2007
	Continence Control Systems completes merger with Colocare Holdings 1 November 2007
	Net Tangible Asset Backing – September 2007 12 October 2007
	BioTech Capital Annual Report 2007 19 September 2007
	Net Tangible Asset Backing – August 2007 4 September 2007
	BTC 2007 Notice of Annual General Meeting 31 August 2007
	BTC 2007 Proxy Form 31 August 2007
	BTC 2007 Financial Report 28 August 2007
	BTC 2007 Appendix 4E 28 August 2007
	Net Tangible Asset Backing - July 2007 6 August 2007
	Neurodiscovery shareholders approve second tranche investment by BioTech Capital 11 July 2007
	Net Tangible Asset Backing - June 2007 4 July 2007
	Boardroom Radio Broadcast – Investment in Sensear 20 June 2007
	BTC – to invest $2m and become largest shareholder in hearing technology company Sensear Pty Ltd 19 June 2007
	BTC – becoming a substantial shareholder in Neurodiscovery 8 June 2007
	Net Tangible Asset Backing - May 2007 5 June 2007
	Boardroom Radio broadcast – Investment in Neurodiscovery 31 May 2007
	BioTech Capital to become largest shareholder in Neurodiscovery 30 May 2007
	Net Tangible Asset Backing – April 2007 3 May 2007
	Stem Cell Sciences closes offer early and oversubscribed 3 April 2007
	Net Tangible Asset Backing – March 2007 2 April 2007
	Stem Cell Sciences opens $12m capital raising and ASX dual listing 20 March 2007
	Net Tangible Asset Backing – February 2007 6 March 2007
	BioTech Capital Ltd Dec 2006 Half Yearly Report to Shareholders 27 February 2007
	BioTech Capital Ltd Dec 2006 Half Yearly Financial Report 27 February 2007
	BioTech Capital Ltd Dec 2006 Appendix 4D 27 February 2007
	Ceasing to be a substantial shareholder (CCE) 23 February 2007
	Stem Cell Sciences licenses neural stem cell technology to Merck 21 February 2007
	Audio Broadcast – BioTech Capital Investor Showcase - Starpharma & XRT 13 February 2007
	Net Tangible Asset Backing – Jan 2007 12 February 2007
	Change in substantial shareholding – Phylogica 30 January 2007
	Change in substantial shareholding – Clinical Cell Culture 30 January 2007
	Invitation to investor showcase 15 January 2007
	Share buyback Appendix 3D 12 January 2007
	Net Tangible Asset Backing – December 2006 10 January 2007
	Change in substantial shareholder – Select increases stake 15 December 2006
	Net Tangible Asset Backing – November 2006 14 December 2006
	Change of Registered Office 01 December 2006
	BTC 2006 Annual General Meeting Presentation 23 November 2006
	BTC 2006 Annual General Meeting Results 23 November 2006
	Net Tangible Asset backing - October 2006 1 November 2006
	Proxy Form AGM 2006 23 October 2006
	Notice of Meeting AGM 2006 23 October 2006
	Appendix 3B - new issue announcement 5 October 2006
	Net Tangible Asset backing - September 2006 5 October 2006
	Biotech Capital Ltd 2006 Annual Report 29 September 2006
	Quotation of options 26 September 2006
	Preliminary Final Report for the year ending 30 June 2006 13 September 2006
	Appendix 4E for the year ending 30 June 2006 13 September 2006
	Net Tangible Asset Backing - August 2006 8 September 2006
	Change in substantial shareholder - Lazard increases stake 22 August 2006
	Net Tangible Asset Backing - July 2006 2 August 2006
	Change in company secretary and registered office 6 July 2006
	Net Tangible Asset Backing - June 2006 6 July 2006
	Net Tangible Asset Backing - May 2006 6 June 2006
	Correction- Ceasing to be a substantial holder notice 9 May 06 12 May 2006
	Audio broadcast - Biotech Capital Investor Showcase 9 May 2006
	Ceasing to be a substantial shareholder 9 May 2006
	Net Tangible Asset backing - April 2006 8 May 2006
	Net Tangible Asset backing - March 2006 4 April 2006
	Becoming a substantial shareholder 20 March 2006
	Biotech Capital Ltd 2005 half yearly commentary 20 March 2006
	Biotech Capital Ltd 2005 half yearly results 15 March 2006
	Change in substantial shareholding 14 March 2006
	Change in Company Secretary and Registered Office 3 March 2006
	Net Tangible Asset backing - February 2006 3 March 2006
	Change of substantial holder interest - Clinical Cell Culture 9 February 2006
	Net Tangible Asset backing - January 2006 7 February 2006
	Becoming a substantial shareholder 17 January 2006
	Net Tangible Asset backing - Dec 2005 10 January 2006
	Net Tangible Asset backing - Nov 2005 12 December 2005
	Chairman's address - 2005 Annual General Meeting 28 November 2005
	Managing Director's presentation - 2005 Annual General Meeting 28 November 2005
	Stem Cell Sciences secures source of adult-derived stem cells 16 November 2005
	Stem Cell Sciences licences technology to Lexicon Genetics 4 November 2005
	On -market share buyback Appendix 3C 2 November 2005
	On market share buyback 2 November 2005
	Net Tangible Asset Backing - October 2005 1 November 2005
	BioTech Capital Ltd 2005 Notice of Meeting 21 October 2005
	BioTech Capital Ltd 2005 Annual Report 21 October 2005
	Kathryn Greiner appointed Chairman 18 October 2005
	Net Tangible Asset backing - Sep 05 13 October 2005
	Stem Cell Sciences enters into agreement with Chemicon 7 October 2005
	Preliminary Final Report for Year Ended 30 June 2005 13 September 2005
	Net Tangible Asset Backing - August 2005 12 September 2005
	Stem Cell Sciences signs licence deal with Deltagen 6 September 2005
	XRT secures new investors from UK 29 August 2005
	Stem Cell Sciences - breakthrough neural stem cell technology 17 August 2005
	Net Tangible Asset Backing - July 2005 11 August 2005
	Continence Control Systems commences patient recruitment for first human implants 21 July 2005
	Stem Cell Sciences successfully raises GBP6,000,000 14 July 2005
	Net Tangible Asset Backing - June 2005 12 July 2005
	Stem Cell Sciences moves towards UK listing 23 June 2005
	Net Tangible Asset Backing - May 2005 9 June 2005
	XRT signs technology licence agreement with Gatan 1 June 2005
	Net Tangible Asset Backing - April 2005 9 May 2005
	XRT signs landmark collaboration with world leader 6 April 2005
	Net Tangible Asset Backing - March 2005 5 April 2005
	Phylogica to list on Australian Stock Exchange 29 March 2005
	Net Tangible Asset Backing - February 2005 10 March 2005
	BioTech Capital Ltd Dec 2004 half yearly results 28 February 2005
	BioTech Capital Ltd Dec 2004 half yearly commentary 28 February 2005
	Net Tangible Asset Backing - January 2005 16 February 2005
	PKS wins major tender 8 February 2005
	Phylogica shareholders approve BTC investment 25 January 2005
	Net Tangible Asset Backing - December 2004 7 January 2005
	BTC invests $2m for 28% stake in Phylogica 20 December 2004
	Continence Control Systems awarded R&D START Grant 17 December 2004
	Net Tangible Asset Backing - November 2004 3 December 2004
	Biotech Capital disposes of its Xenome stake 25 November 2004
	Huntley Investments BTC research note 24 November 2004
	2004 Annual General Meeting Results 22 November 2004
	Net Tangible Asset Backing - October 2004 3 November 2004
	Investment in Prima Biomed 26 October 2004
	Net Tangible Asset Backing - September 2004 8 October 2004
	Net Tangible Asset Backing - August 2004 3 September 2004
	Proteome Systems lodges prospectus with ASX 18 August 2004
	Net Tangible Asset Backing - July 2004 12 August 2004
	Xenome commences Phase I human clinical trials 20 July 2004
	Net tangible Asset Backing - June 2004 6 July 2004
	BioTech Capital announces changes to the Board of Directors 1 July 2004
	BTC completes tenth investment taking stake in Continence Control Systems 24 June 2004
	Xenome IND approved triggering second tranche investment 23 June 2004
	Net Tangible Asset Backing - May 2004 7 June 2004
	Change in substantial shareholder 2 June 2004
	Net Tangible Asset Backing - April 2004 7 May 2004
	Xenome files IND application with US FDA 22 April 2004
	Net Tangible Asset Backing - March 2004 13 April 2004
	Invests in Starpharma 18 March 2004
	Net Tangible Asset backing - Feb 2004 11 March 2004
	Dec 2003 half yearly report to shareholders 9 March 2004
	Notice of meeting of shareholders 9 March 2004
	Change in substantial shareholding 1 March 2004
	Net Tangible Asset backing - Jan 2003 13 February 2004
	Net Tangible Asset backing - Dec 2003 15 January 2004
	Net Tangible Asset backing - Nov 2003 11 December 2003
	Biotech Capital to acquire management rights and equity from Challenger 24 December 2003
	BTC Valuation policy and Oct NTA 12 November 2003
	BTC 2003 AGM Chairmans address and presentation 11 November 2003
	Alchemia announces IPO 10 November 2003
	Xenome secures $3.2m START grant 5 November 2003
	Change of Director's Interest Notice for Ms Lee 15 October 2003
	Change of Director's Interest Notices for Messrs Ireland, Karelis and Davidson 10 October 2003
	Appendix 3B - Exercise of Options 9 October 2003 ASX Announcement
	C3 announces European partner and files for European regulatory approval 10 September 2003
	Bonus Options Issue: Letter to shareholders 29 August 2003
	Bonus Options Issue 26 August 2003
	C3 signs contract manufacturer for ReCell 30 July 2003
	BTC invests in Stem Cell Sciences 23 July 2003
	Pre-clinical studies demonstrate efficacy of Xen 2174 15 July 2003
	Proposed CCE investment: Update 25 June 2003
	Alchemia secures additional funding 20 June 2003
	Xenome secures $6 million investment 18 June 2003
	BTC to acquire 19.99% stake in C3 18 June 2003
	Xenome awarded key European patent 20 May 2003
	Xenome awarded $250,000 BIF Grant 7 May 2003
	Proteome Systems/Charles River launch new facility 14 April 2003
	BioTech Capital Dec 2002 half yearly report to shareholders 13 March 2003
	Proteome Systems/Nestle collaboration 13 December 2002
	Xenome/TheraSci drug discovery collaboration 11 December 2002
	Alechemia granted key international patents 30 November 2002
	Biocomm brokers international licensing deal 08 November 2002
	Proteome Systems forms joint-venture with Charles River Laboratories 09 October 2002
	XRT/EDAX global distribution partnership 23 August 2002
	Purchase of shares by Director 24 July 2002
	Professor Tony Basten joins BioTech Board 1 July 2002
	Biocomm investment concluded 11 June 2002
	PSL Japan ProteomIQ ASX release 04 June 2002 04 June 2002
	Alchemia/CelTor Biosystems collaboration 16 April 2002
	Change in Director's interests 2 April 2002
	Alchemia/Euroscreen collaboration 2 April 2002
	Xenome enters into partnership with Icagen 26 March 2002
	Proteome Systems/ Cystic Fibrosis Foundation Strategic Alliance 21 March 2002
	BioTech Capital enters into agreement to acquire stake in Biocomm 15 March 2002
	Xenome enters into collaboration with Ionix Pharmaceuticals 6 March 2002
	Xenome ASX release 25 Feb 2002 Feb 25 2002
	PSL Options ASX release 21 Feb 2002 Feb 21 2002
	Board Change Feb 15 2002
	Chairman's Address 2001 Annual General Meeting 29th November 2001
	IBM and Proteome Systems In Strategic Alliance to Advance Protein Research and Drug Discovery November 21 2001
	BioTech Capital Ltd announces completion of fifth investment acquiring 27% stake in Xenome Ltd November 15 2001
	Notice of Director's Interests November 15 2001
	X-Ray Technologies announces maiden sale of it’s X-Ray Ultra Microscope imaging technology 13 November 2001
	Proteome Systems Completes Second Round Capital Raising At Significantly Higher Valuation 18 September 2001
	Preliminary Final Report* August 24 2001
	Proteome Systems enters into Strategic Technology and Research Partnership with Leading group in the USA August 24 2001
	Notice of Director's Interest August 09 2001
	Proteome Systems announces collaboration for key discovery program June 29 2001
	Alchemia announces award of new $4.3m Federal Government R&D START Grant 30 May 2001
	Proteome Systems to acquire Niche Innovation and expand its manufacturing operations 18th May 2001
	Proteome Systems announces breakthroughs on array and characterization of membrane proteins, rare proteins and basic proteins Sydney, Australia 17th May 2001
	Alchemia appoints leading industry figure as new chairman 5 April 2001
	BioTech Capital Ltd announces investment in X-Ray Technologies 8 March 2001
	BioTech Capital Ltd announces investment in Alchemia 1 March 2001
	Notice Of Director's Interests ASX Announcement
	BioTech Capital Ltd announces second investment 21 December 2000
	Proteome Systems achieves key technical milestone on Chemical Printer proteomics instrument 4 December 2000
	Proteome Systems Ltd achieves key technical milestones and expands alliances 4 December 2000
	Biotech Capital Limited - Share Price Update 2000-11-28 ASX-SIGNAL-G HOMEX - Sydney
	Sigma-Aldrich and Proteome Systems announce Proteomics alliance Biotech Capital Limited 26th October 2000
	Directors wish to announce that the unaudited net asset backing... 11th October 2000 HOMEX - Sydney
	Biotech Capital Ltd - Notice of Director's Interests 4th October 2000 ASX-SIGNAL-G HOMEX - Sydney
	Proteome Systems & Gradipore Collaborate on Proteomic Gel Technologies Media Release - 28 September 2000
	GeneBio Appointed as Exclusive Worldwide Distributor of Proteome Systems’ Glycosylation Database Press Release September, 2000
	$3.3m Commonwealth R&D Grant Offer supports major Proteomics initiative of Proteome Systems 26 September 2000
	Proteome Systems completes capital raising at A$166million valuation and receives offer of Australian Government grant for new technology development Press Release - 26 September 2000
	Biotech Capital Ltd ASX Release - 26 September 2000
	Biotech Invests in Proteome BioTech Update
	Challenger's Biotech Capital Ltd makes first acquisition and expects to list on ASX early next week Press Release
	Biotech Fund Push The Daily Telegraph Friday July 14 2000